Last reviewed · How we verify
NCT06662474
Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches
NA trial testing 1. cognitive stimulation in Cognitive Impairment in 120 participants. Not yet recruiting.
1 November 2026
Quick facts
| Lead sponsor | Grigore T. Popa University of Medicine and Pharmacy |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 120 |
| Start date | 1 November 2024 |
| Primary completion | 1 November 2026 |
| Estimated completion | 31 December 2026 |
Drugs / interventions tested
- 1. cognitive stimulation
- 2. psychoeducation and cognitive stimulation
- 3. no intervention
Conditions studied
- Cognitive Impairment — all drugs for Cognitive Impairment →
- Chemobrain — all drugs for Chemobrain →
Sponsor
Grigore T. Popa University of Medicine and Pharmacy
Who can join
18 and older, female only, with Cognitive Impairment or Chemobrain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim is to conduct a prospective study with three arms, involving non-metastatic breast cancer patients who underwent chemotherapy as part of their treatment and were on a form of hormone therapy at the time of study inclusion. The trial consists of identifying the presence of cognitive decline and following up on methods of preventing its accentuation. The goal of this clinical trial is to assess if psychoeducation and cognitive stimulation work to decrease the intensity of cognitive impairment. It aims to answer the following main questions: * The implementation of such interventions improves both the dysfunction quantified by objective tests but also the individual's perception of it. * The implementation changes the patients' quality of life. Researchers will compare three study groups, each with instructions to complete one of the related 12-week programs, to see if there are any changes. Depending on the group in which the patient was randomly assigned, the interventions are : * First group - will engage in exercises like sudoku, word games, and painting by numbers for 30 minutes per day, three days per week, for a duration of 12 weeks * the second group will engage in exercises like sudoku, word games, and painting by numbers for 30 minutes per day, three days per week, for a duration of 12 weeks and also hold open group meetings for psychoeducation (1 meeting every 2 weeks, 6 meetings in total). * Group 3 is considered a control group, consisting of people who maintained their lifestyle up until their inclusion in the study without following additional measures
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06662474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Impairment
Currently open trials in the same condition.
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07396779 — Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog · NA · active not recruiting
- NCT07084831 — A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment i · Phase 3 · recruiting
- NCT07125378 — Living Independence Through Functional Training · Phase 1, PHASE2 · recruiting
- NCT07268079 — Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality · recruiting
Other Grigore T. Popa University of Medicine and Pharmacy trials
Trials by the same sponsor.
- NCT07437755 — Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cir · NA · recruiting
- NCT07237451 — Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients · recruiting
- NCT07067294 — Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Cataract Surgery · NA · completed
- NCT06639841 — Effectiveness of Virtual Reality Psychotherapy and Yoga on Student Performance Anxiety · NA · active not recruiting
- NCT07181668 — Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06662474 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Grigore T. Popa University of Medicine and Pharmacy
- Last refreshed: 30 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06662474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing